DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES
The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a B cell proliferative disorder by...
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English French |
| Published |
12.05.2022
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).
La présente invention concerne le traitement de sujets ayant des troubles prolifératifs cellulaires positif à CD20 (par ex., des troubles prolifératifs des lymphocytes B, tels que les lymphomes non hodgkiniens). Plus spécifiquement, l'invention concerne le traitement de sujets ayant un trouble prolifératif des lymphocytes B par administration intraveineuse d'un anticorps bispécifique anti-CD20/anti-CD3 (par ex., le mosunétuzumab). |
|---|---|
| AbstractList | The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as non-Hodgkin's lymphomas). More specifically, the invention pertains to the treatment of subjects having a B cell proliferative disorder by intravenous administration of an anti-CD20/anti-CD3 bispecific antibody (e.g., mosunetuzumab).
La présente invention concerne le traitement de sujets ayant des troubles prolifératifs cellulaires positif à CD20 (par ex., des troubles prolifératifs des lymphocytes B, tels que les lymphomes non hodgkiniens). Plus spécifiquement, l'invention concerne le traitement de sujets ayant un trouble prolifératif des lymphocytes B par administration intraveineuse d'un anticorps bispécifique anti-CD20/anti-CD3 (par ex., le mosunétuzumab). |
| Author | LI, CHIUNG O'HEAR, CAROL ELAINE BENDER, BRENDAN CHRISTIAN |
| Author_xml | – fullname: BENDER, BRENDAN CHRISTIAN – fullname: LI, CHIUNG – fullname: O'HEAR, CAROL ELAINE |
| BookMark | eNrjYmDJy89L5WRwcvEP9vRzV3DzD1IICXJ1DPF19QtRCPcM8VBw9Avx1HV2MTLQh7KMFZw8gwNcnT3dPJ3Bsk7-Lp6uwTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN7Z0djQ0szU2NLR0JgIJQCKESwH |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | DOSAGE POUR LE TRAITEMENT AVEC DES ANTICORPS BISPECIFIQUES ANTI-CD20/ANTI-CD3 |
| ExternalDocumentID | CA3196539A1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_CA3196539A13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:00:36 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_CA3196539A13 |
| Notes | Application Number: CA20213196539 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220512&DB=EPODOC&CC=CA&NR=3196539A1 |
| ParticipantIDs | epo_espacenet_CA3196539A1 |
| PublicationCentury | 2000 |
| PublicationDate | 20220512 |
| PublicationDateYYYYMMDD | 2022-05-12 |
| PublicationDate_xml | – month: 05 year: 2022 text: 20220512 day: 12 |
| PublicationDecade | 2020 |
| PublicationYear | 2022 |
| RelatedCompanies | GENENTECH, INC |
| RelatedCompanies_xml | – name: GENENTECH, INC |
| Score | 3.4050808 |
| Snippet | The present invention relates to the treatment of subjects having CD20-positive cell proliferative disorders (e.g., B cell proliferative disorders, such as... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | DOSING FOR TREATMENT WITH ANTI-CD20/ANTI-CD3 BISPECIFIC ANTIBODIES |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220512&DB=EPODOC&locale=&CC=CA&NR=3196539A1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PT4MwFH5ZplFvOjXOX-nBcCMDCosciIEWBJMB2VB3W6B0yS5scRj_fduGTS96aZo2eWlf-vq-1_Z9BXiwmMPdyrJ12-GicOtSf3S5pK0s66riTl1ime88Scfxq_0yd-Y9WO1yYRRP6JciRxQWxYS9t2q_3vwcYlH1tnI7qlaiaf0UFR7VuuhYZo2alkYDL8wzmhGNEI_4Wjr15EpzsOuLQOlAomhJsx--BTIpZfPbo0SncJgLYU17Bj3eDOCY7D5eG8DRpLvvFtXO9LbnENBslqTPSERtqJiGfiFZ-NF7UsTIT4tEJ9QyRl0NoyCZ5SFJooSo3iCTsO8CUBQWJNbFYBb7iS-Ivx82voR-s274FSABWsZc4BoDl2ObsbpaSphWmqxmuDSYPYThn2Ku_-m7gROpQXk1blq30G8_Pvmd8Lhtda909Q1WR38- |
| link.rule.ids | 230,309,786,891,25594,76904 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NT8IwFH8haMSbokb87MHstsC-0B0Ws3Wbq8JGoCq3ZetKwmUQmfHft10GetFL07RJ8_rS175fX9-vAHc6s7id66ZqWlwUdpGpDzaXtJVZkefcKjJD5juP42H0aj7PrXkLlttcmJon9KsmRxQWxYS9V_V-vf65xPLrt5Wbfr4UTavHkDq-0qBjmTWq6YrvOcEk8ROsYOxgV4mnjlxplmG7Aijt3QtEKGn2gzdPJqWsf58o4RHsT8RgZXUMLV52oYO3H6914WDcxLtFtTG9zQl4fjIj8RMSqA3RaeBSycKP3gmNkBtTomJfH_SbmoE8MpsEmIQE171eIt2-U0BhQHGkCmHS3cRT7O7ENs6gXa5Kfg5IOC1DLvyagZENTcaKfCHdtExjBTOyATN70PtzmIt_-m6hE9HxKB2R-OUSDqU2ZZhc06-gXX188mtx-lb5Ta23b2-8gik |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DOSING+FOR+TREATMENT+WITH+ANTI-CD20%2FANTI-CD3+BISPECIFIC+ANTIBODIES&rft.inventor=BENDER%2C+BRENDAN+CHRISTIAN&rft.inventor=LI%2C+CHIUNG&rft.inventor=O%27HEAR%2C+CAROL+ELAINE&rft.date=2022-05-12&rft.externalDBID=A1&rft.externalDocID=CA3196539A1 |